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Abstract 
 
Spinal afferent neurons are of particular interest because, in contrast to vagal afferents, they 
play the major role in detection and transduction of painful stimuli from internal (visceral) organs. 
Recently, there have been major technical advances in our ability to understand the innervation 
of spinal afferent endings in visceral organs. Although it is well known that the sensory neurons 
of spinal afferents reside within dorsal root ganglia (DRG), identifying the nerve endings of spinal 
afferents in internal organs has been more challenging. This has been due, largely, to a lack of 
techniques to selectively label spinal afferents. To get around this problem, we recently 
developed a surgical technique in live mice that allows selective labelling of only spinal afferent 
axons and their endings. This approach revealed an unexpectedly complex and diverse array of 
different types of varicose and non-varicose spinal afferent endings in visceral organs, 
particularly the large intestine. In total, 13 different types of endings were identified in the terminal 
large intestine, originating from lumbosacral DRGs. The stomach, esophagus, bladder and 
uterus had noticeably less diversity and density of spinal afferent endings compared with the 
distal large bowel. Taken together, compared to vagal afferent endings, spinal afferent endings 
(at least in the large intestine) show greater morphological diversity and complexity. We discuss 
new insights into the innervation of spinal afferent endings in visceral organs and the advantages 
of surgically exposing DRGs in live mice.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
 
In vertebrates, the ability to perceive painful stimuli is an evolutionary adaptation to prevent injury 
or death. Some humans are born with a complete inability to detect any pain (7) and whilst these 
people can live a normal life span, they often unconsciously inflict harm (sometimes lethal) on 
their bodies. Painful stimuli are normally detected by nociceptors, whose transduction sites 
respond to potentially damaging (painful) stimuli, by sending action potentials to the spinal cord 
and brain, a process broadly referred to as nociception. Deficits in specific classes of spinal 
afferents can lead to substantially reduced nociception from visceral organs (38). Therefore, 
understanding the characteristics of the different types of spinal afferent endings in the visceral 
organs can provide us with valuable new clues regarding nociception.  
 
There is clear evidence in mammals, that most, if not all painful stimuli arising from internal 
organs are detected by spinal afferent neurons, whose cell bodies lie in DRG (12, 38). This was 
determined largely by lesion studies to the vagus nerve which failed to block painful sensations, 
whereas lesions to the spinal cord abolished all visceral sensation (12), including those of a 
noxious origin (12). Despite our understanding of the location of the cell bodies of spinal afferent 
neurons within DRG (12, 33), one major unresolved mystery is the location of the nerve endings 
of spinal afferents that actually convert noxious stimuli into nerve action potentials, that are 
ultimately relayed to the CNS (4, 36). The major reason why it has been so difficult to identify 
the location of spinal afferent endings in visceral organs is because, unlike vagal afferent 
neurons, which are readily accessible for injection of neuronal tracers during surgery, DRG are 
not easily accessed surgically in live animals, particularly in small laboratory animals. Identifying 
spinal afferent nerve endings in the gastrointestinal (GI) tract has the added complication that 
the wall of the GI-tract has its own completely independent nervous system, known as the enteric 
nervous system (3, 8, 26) and many of the neurochemical markers that are expressed in DRG 
(and hence are present in spinal afferent nerve endings within the gut wall) are also expressed 
in enteric neurons; such as substance P (5, 6) and calcitonin gene related peptide (CGRP) (9). 
Because a significant proportion of spinal afferent endings ramify within the enteric nervous 
system (ENS) (14, 30), attempts to disentangle the nerve endings of spinal afferents from enteric 
nerve axons, or other extrinsic autonomic nerve axons has proved effectively impossible, when 
using antibodies alone.  
 
Anatomical features of spinal afferents and other sensory neurons 
 
Spinal afferents are not the only sensory neurons in vertebrates. A number of cranial nerves are 
also either pure sensory nerves (e.g. cranial nerves 1, 2 & 8) or, are mixed sensory and motor 
nerves (e.g. cranial nerves, 5, 7, 9 & 10). However, most of the cranial nerves innervate the 
either above the shoulders, or at shoulder level and the vagus nerve (which contributes to 
visceral sensation) is the only cranial nerve that innervates organs below the shoulders, at least 
in humans. Therefore, it has become clear that by far most visceral and somatic sensation in 
vertebrates, either at a noxious (painful) or innocuous (physiological) level is detected by spinal 
afferents. Once activated, spinal afferents send sensory information into the spinal cord via the 
dorsal nerve roots and into the dorsal horn, where they can either make their first synapse and 
travels up the spinothalamic tract, or travel up the dorsal column, without making a synapse until 
reaching the brainstem. Either way, lesions to the dorsal nerve roots block all painful and non-
painful sensations.   
 
Although DRG lie just outside the spinal cord and send projections directly into the spinal cord, 
DRGs are officially recognized as part of the peripheral nervous system. Therefore, it is 
important to recognize that while the cell bodies of all spinal afferents reside in DRG, they can 
have very long axons that project long distances (without a synapse) (i.e. >1m) to reach their 
nerve endings in distal extremities, like the feet or hands. Commonly, spinal afferents and the 
mechanisms underlying their sensory transduction are studied without neural continuity to their 
cell bodies in DRG. Hence, it is clear that sensory transduction and the generation of action 
potentials in spinal afferent nerve endings does not require their nerve cell bodies. In humans, 
there are 31 pairs of spinal nerves, each with a dorsal and ventral nerve root that are located all 
along the full length of vertebral column (C1 to S5), remembering that the spinal cord itself stops 
at L1 vertebrae and does not itself extend all the way down the vertebral column. 
 
It is important to remember that there are also a population of sensory neurons in the wall of the 
gastrointestinal tract, in the enteric nervous system (11, 31), that do not require any central or 
peripheral neural pathways to generate neural reflexes and complex motor patterns in the 
gastrointestinal tract (26). 
 
Early anterograde tracing techniques developed in vitro to label spinal afferents  
 
Anterograde tracing in vitro was developed in the late 1990’s from lesioned extrinsic nerve trunks 
as they enter isolated segments of intestine (34). This approach has been used to successfully 
label a class of spinal afferent ending that innervates blood vessels in the small intestine (24), 
which function as high threshold mechanoreceptors, and also low threshold mechanoreceptors 
(rectal intraganglionic laminar endings, rIGLEs) in the rectum (4, 14), including intraganglionic 
lamellar endings (IGLEs) in the esophagus (35) and stomach (37). In the mouse colon, a class 
of intramuscular endings have also been identified in the smooth muscle (28) and myenteric 
ganglia (27). However, it was not possible to be sure whether the nerve endings labeled from 
extrinsic nerve trunks were spinal afferents, because many other classes of extrinsic efferent 
and afferent axons were also labeled, such as sympathetic efferents, parasympathetic efferents 
or possibly collaterals of intestinofugal afferents.  
 
Development of selective anterograde tracing of spinal afferents and their nerve endings 
 
Dorsal root ganglia are easy to isolate from euthanized verterbrates. However, accessing DRG 
in live animals as a survival surgery is difficult. This is in contrast to nodose and jugular ganglia 
(that give rise to vagal afferents) which are readily accessible during surgery. DRG are smaller 
(about 1mm wide in mice) and are difficult to expose in vivo, without substantial blood loss during 
surgery. We spent many months developing the survival surgery technique, whereby DRGs 
could be reliably exposed in vivo, then injected with tracers or viruses, as a survival surgery 
(13)(Fig.1). Many neuronal tracers were tested. None were as successful at revealing the fine 
morphological features of nerve endings in visceral organs, except the high molecular weight 
dextran biotin (13). Using this tracer, it is now possible to visualize in high resolution (down to 
single varicosity level) all the different types of nerve endings of only spinal afferents that 
innervate different visceral organs (13)(Fig.1C). In the large intestine, we first used this approach 
to identify all the different types of spinal afferent nerve endings in this region (30)(Fig.1C). We 
were mesmerized by unexpectedly complex range of different types of spinal afferent nerve 
endings that were uncovered by this selective tracing approach. We were most surprised at how 
many branching axon terminal endings could arise from a single axon. It was not uncommon to 
identify a single axon entering the large intestine that had >100 axon terminal endings; and these 
could innervate multiple anatomical layers within the large bowel. In general, at least from our 
findings in the terminal colorectum, it seemed to suggest that compared to skin, the spinal 
afferent innervation of viscera (at least the colorectum) appears to have evolved a more 
extensive and diverse array of sensory endings. All of the endings we identified in the terminal 
large bowel (30) of course excluded any additional sensory innervation provided by 
intestinofugal afferents, vagal afferents or intrinsic sensory neurons.  
 
How to correlate the nerve endings arising from a single spinal afferent axon 
We found that if many DRGs were injected in the same mouse with dextran biotin, many axons 
were labeled in the target organ. The problem with this was that many axons typically overlapped 
each other making it almost impossible to follow the path of single axons and then directly 
correlate the trajectory of a single axon with its nerve terminal morphology. To get around this 
problem, we found that by injecting minute quantities of tracer (~50-100nL dextran biotin) into 
only single DRGs unilaterally, this allowed us to visualize very small numbers of axons in the 
peripheral organ. This was very exciting, because for the first time in a visceral organ, we could 
directly visualize the point of entry of single spinal afferent axons into a peripheral organ, then 
follow their trajectory without ambiguity to their endings, without interference from other axons. 
This allowed us to determine: (1) how many endings arise from a single axon and (2) which 
many anatomical layers are innervated by a single axon. In the terminal colon, we have found 
that a single axon can innervate 3 different anatomical layers and give off literally hundreds of 
axon terminals that branch numerous times within the target organ (Fig.2).  
 
Can transgenic reporter mice be used to identify spinal afferent nerve endings ? 
 
One way to visualize the nerve endings of spinal afferents in peripheral organs, without surgical 
intervention (and injection of DRG) would be to generate a transgenic mouse that expresses a 
fluorescent reporter driven by a promoter that is only expressed in DRG neurons. These mice 
have been generated (10, 17). However, it has been found from our experience that the 
expression of the reporter is high in the cell bodies of the DRG (sensory neurons), but is 
considerably weaker in the peripheral terminals. This has precluded detailed characterization of 
the ultra-fine morphological details of the nerve endings of spinal afferents. Also, any labeled 
nerve axons or endings cannot be unequivocally confirmed to have originated from DRG 
sensory neurons, because, as mentioned many sensory peptides are expressed in both DRG 
and enteric neurons. Indeed, it is known that CGRPα is strongly expressed in DRG, but weakly 
expressed in enteric neurons of the gastrointestinal tract (10, 18). Using this knowledge, in a 
previous study, the green fluorescent protein (GFP) was knocked into the CGRPα locus of mice 
(17). This allowed recordings from the cell bodies of CGRPa expressing nerves in the skin and 
viscera using ratiometric calcium dyes (Fura-2) (17). Also, recently we generated a transgenic 
mouse, in which mCherry expression was driven by the CGRPα promoter (10). We generated 
this mouse so that we could use non-ratiometric calcium indicators (Fluo-4) to record from nerve 
endings that express CGRPα (25), because GFP fluorescence would overlap with Fluo-4. Using 
this new mouse, we found that expression of mCherry was high in cell bodies in DRG (10), but 
weaker in nerve terminals. This precluded identification of the fine structure of spinal afferent 
endings in visceral organs. Because transgenic expression of mCherry was not able to reveal 
fine morphological details of single nerve axons, we realized it was necessary to develop a 
different approach to selectively identify spinal afferent axons in viscera.  
 
Different types of spinal afferent endings in the lower gastrointestinal tract 
 
Following injection of lumbosacral DRGs in live mice, we were astonished to uncover a total of 
13 distinct types of spinal afferent nerve ending ramifying throughout all different layers of the 
terminal large bowel (30). We were amazed at the complexity of some their endings and how 
extensively they ramified within different anatomical sites in the large intestine, many with unique 
morphologies that have not been described previously (Fig.2D). The greatest number of endings 
was found in the myenteric ganglia (Fig.2D-F), submucosa (Fig.3A & B) and circular muscle, 
which collectively comprised 82% of all the spinal afferent endings identified in the large bowel. 
The fewest number of spinal afferent nerve endings were found in the longitudinal muscle, 
submucosal ganglia and blood vessels. In our recent unpublished data, the innervation of the 
colorectum in mice via the thoracolumbar DRGs is considerably less complex than via the 
lumbosacral DRGs. The spinal afferent innervation of the colorectum from lumbosacral DRGs is 
of supreme interest to us because from our lesion studies (12), we found that visceral pain from 
the colorectum is conducted, primarily, if not solely  from the lumbosacral DRG pathway under 
healthy control conditions, and not thoracolumbar DRGs as is often thought.  
 
We were fascinated to find that in myenteric ganglia of the terminal large intestine there were 
two major classes of spinal afferent endings (30). The most common class was a novel type of 
ending that has not been described previously that consisted of a single axon that entered a 
myenteric ganglion, then ramified throughout the ganglion, lacking any complex morphological 
structure at its terminal ending but consisted of multiple varicosities. We described these endings 
as intraganglionic varicose endings (IGVEs)(Fig.2D & E). Of all IGVEs identified, the majority 
(66%) were CGRP positive (30). In other animals, some IGVEs were weakly varicose and also 
terminated as a simple bare axon (30). These could not have represented swollen cut ends or 
expansion bulbs of damage axons because anterograde tracing, fixing and 
immunohistochemically procedures were performed on freshly fixed whole mounts with no 
anatomical layers of the gut dissected. The close apposition of IGVEs to myenteric neurons 
notionally supports the concept of potential bidirectional communication between the enteric 
nerves and extrinsic spinal afferents, but at this stage we are not aware of any direct 
morphological communication. Rectal IGLEs were observed in myenteric ganglia of mouse large 
intestine (Fig.2F), but they were far less common and only comprised 5% of the total proportion 
of nerve endings identified. rIGLEs have not been identified in the mouse intestine previously, 
but showed similar morphological features as those described in guinea-pig rectum (14). That 
is, they consisted of flattened laminar endings that ramified throughout a single myenteric 
ganglion. None of the rIGLEs were immunoreactive to CGRP (30), which is consistent with 
rIGLEs in guinea-pig intestine (14). Perhaps even more interesting was the observation, that, 
albeit very rarely, rIGLEs could be identified in submucosal ganglia. The notion that spinal 
afferent endings actually provide a direct innervation of the gastrointestinal mucosa had not been 
confirmed until recent anterograde tracing from lumbosacral DRG (30).  
 
Spinal afferent innervation of the upper gastrointestinal tract 
 
Whilst the nerve endings of vagal afferents have been extensively characterized in the 
esophagus and stomach, following injections of neuronal tracers into nodose and jugular ganglia 
(1, 2, 20-22), very little was known about spinal afferent endings in the esophagus of mammals 
(16, 19) and nothing about the stomach of mammals. One previous study injected thoracic DRG 
of cats and identified nerve fibres in the lower esophagus that ramified around myenteric neurons 
which were also detected in circular muscle and blood vessels (15, 16). However, unfortunately, 
the actual nerve endings of these labeled fibres were not resolved. In rats, another study showed 
that injection of DiI into thoracic DRGs revealed varicose axons in myenteric ganglia of the rat 
esophagus (19). 
 
Recently, we injected thoracic DRGs in live mice to identify the spinal afferent innervation of the 
upper GI-tract (29). It was found that there was considerably less complexity in the different 
types of spinal afferent endings in the stomach compared with the colorectum. A total of 8 
different types were identified in full thickness specimens of mouse stomach (29). Because 
comparatively few DRG neurons innervate the stomach, we found that in order to identify any 
spinal afferent axons, or endings in the stomach, typically 1 out of every 8 mice would reveal  
any labelling (29). In the esophagus the success ratio of labelling was even lower with about 1 
out of every 10 mice injected (with at least 4 DRGs filled with tracer) revealing any labelled 
axons. Hence, many mice had to be injected to visualize any endings. In the esophagus, we 
only found a single major type of ending that consisted of varicose axons in myenteric ganglia 
(IGVEs) that were very similar to the IGVEs identified in the colorectum (29). The identified IGVE 
endings in the esophagus we identified in mice were similar to findings from Dr. Neuhubers’ 
group, where anterograde tracing from thoracic DRGs revealed varicose endings in myenteric 
ganglia of rat esophagus (19).  
 
Spinal afferent endings in the uterus and urinary bladder  
 
Spinal afferent endings are readily labelled in mouse bladder following L6-S3 DRG injections 
(Fig.4). Almost all labelled endings are immunoreactive to CGRP. Similar to the findings in the 
colorectum, single labelled spinal afferent axons that entered the bladder often showed multiple 
bifurcations, branching numerous times and provided many axon terminal endings. A number of 
different types of endings have been identified in mouse bladder following lumbosacral DRG 
injections that predominantly innervating the detrusor muscle. Our work in progress suggests 
that following thoracolumbar DRG injections a high proportion of the labelled spinal afferent 
endings innervate the urothelium (See Fig.2B &C). Spinal afferent axons and endings have been 
labelled in mouse uterus following thoracolumbar DRG injections (T8-L3). They enter the uterine 
horns via blood vessels, then branch into the smooth muscle of the myometrium ending as 
simple-type endings with unspecialized endings (Fig.3C), all of which to date have been CGRP 
immunoreactive (Fig.3D). To date, we have labelled most spinal afferents uterine smooth muscle 
following thoracolumbar, rather than lumbosacral DRG injections.  
 
New technique to record directly from spinal afferent nerve endings 
 
Until recently, all recordings from spinal afferents have been made from axons or cell bodies 
outside the peripheral organ they innervate, which is a long way from where sensory 
transduction takes place. An important step forward is the ability to record the dynamic changes 
in excitability directly from spinal afferent endings within a visceral organ. These types of direct 
recordings are vital if we wish to understand the cellular and ionic mechanisms underlying the 
transduction of sensory stimuli into action potentials that ultimately lead to the perception of 
noxious and non-noxious stimuli. Whilst CGRPα and CGRPẞ isoforms are expressed 
differentially in different visceral and somatic organs (23), Calca gene (responsible for CGRPα 
production) is highly expressed in DRG sensory neurons and weakly in enteric neurons 
(including intrinsic sensory neurons) of the gastrointestinal tract (23). It is for this reason that 
transgenic reporter mice that exclusively express CGRPα or CGRPẞ have become so useful in 
organs like the gastrointestinal tract. Using this new mouse, we imaged the stretch activation of 
CGRPα-expressing varicosities along spinal afferent endings. We found that application of 
circumferential stretch to the colon increased the unitary discharge of discrete calcium transients 
in single varicosities along axons of CGRPα-mCherry reporter mice (32). These mice, coupled 
with calcium imaging will prove useful in providing new insights into the mechanisms underlying 
activation of nociceptive pathways from visceral organs. A major advantage of this approach is 
that it is now possible to record and discriminate simultaneously the activity from multiple 
functional classes of enteric neurons in the gut wall at the same time as a major class of extrinsic 
spinal afferent ending that is known to encode nociceptive and non-nociceptive stimuli from 
within the GI-tract.  
 
Conclusions 
 
Our recent surgical development to expose multiple DRGs in live mice has paved the way for 
an exciting number of new experiments that have not been possible in the past, in mice. We 
have been amazed by the detail and intricate complexity of the ramifications of single spinal 
afferent axons and their endings. What is clear so far, is that single axons, at least in the terminal 
colon have multiple sites of innervation, and provide outputs at multiple anatomical levels. 
Whether these outputs are provide only an afferent function, or may also behave functionally as 
efferents is not clear. Surgical exposure of DRGs not only facilitates selective anterograde 
tracing from DRG, but allows viruses to be injected directly into DRGs and light emitting diodes 
(LEDs) to be implanted adjacent to DRGs at any level of the vertebral column for optogenetic 
control of spinal pathways. This provides a great opportunity for direct optogenetic control of 
pain pathways in vivo.  
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A, Diagrammatic representation of the technique to inject dextran biotin into single DRGs in live 
mice. Under anesthesia, a midline incision is made to expose DRGs. Glass microelectrodes are 
used to impale single DRGs and inject small volumes of detran biotin. Because the DRG consist 
only of the sensory neurons of spinal afferents, the advantage of injecting into these ganglia is 
that only spinal afferent axons and their endings will be labelled in multiple visceral and somatic 
organs. This means that none of the efferent (motor) axons exiting the spinal cord will also be 
labelled. Spinal afferents in the large intestine could technically be labelled from either the 
lumbar colonic or rectal/pelvic nerve pathways. B, The major pain pathway to the colon is via 
the rectal/pelvic afferents (in red), whose cell bodies lie in L5-S2 DRG. This was established 
when lesions to rectal nerves abolished the visceromotor response to colorectal distension, 
while lesions to the lumbar colonic nerves had no effect on the VMR responses (12). C, in the 
colorectum, 13 different types of spinal afferent ending have been identified, see (30). To date, 
the colorectum has revealed the most diverse and complex types of spinal afferent endings.  
  
 
Different types of spinal afferent endings in the mouse bladder and colon. A, Shows a complex-
type spinal afferent ending identified in the lamina propria close to the urothelium, after unilateral 
injection of dextran biotin into T8-L4 DRG and given 7 days post-surgery to anterogradely 
transport the tracer to the nerve endings. The arrows indicate unspecialized varicose endings. 
B, Shows CGRP immunoreactivity of the same region shown in panel A. The arrows indicated 
the endings indicated by the arrows in panel A are indeed CGRP immunoreactive. C, shows a 
superimposed image of panels A & B. Arrows indicate colocalization with CGRP. It can be seen 
that the anterogradely labelled endings shown in A, are also shown in B as CGRP 
immunoreactive nerve endings.  D & E, show in mouse colorectum, single spinal afferent axons 
and their intraganglionic varicose nerve endings (IGVEs) labeled in myenteric ganglia, also after 
injections of dextran biotin, but in this case into L6-S4 DRG. F, shows a rectal intraganglionic 
lamellar ending (rectal IGLE) arising from a single axon innervating a single myenteric ganglion 
of colorectum. Rectal IGLEs are rare in mouse colon and consist of short flattened lamellar 
dendrites that are not immunoreactive to CGRP. Each image in D-F is taken from a different 
animal.  
  
 
Spinal afferent endings identified in the mouse colorectum and uterus after anterograde tracing 
from DRG in vivo. A & B, shows “complex-type” endings identified in the submucosa of the 
mouse colorectum. These were obtained from two different mice, after unilateral injection of 
minute volumes of dextran biotin tracer into L6-S4 DRG. C, shows a “simple type” spinal afferent 
ending identified in the myometrium of the mouse uterus after injection of tracer in T8-L4 DRG. 
D, shows CGRP immunoreactivity of the same region shown in panel C. The anterogradely 
labeled ending identified in panel C is shown in D as CGRP-immunoreactive. E, shows a 
superimposed image of panels C & D. The arrows in C, D & E indicate the same anterogradely 
labelled varicosity in C, is CGRP immunoreactive (see D).     
 
A single spinal afferent axon and nerve ending identified in the detrusor muscle of mouse urinary 
bladder. The single axon is labelled after unilateral injection of ~50nL of dextran biotin into L6-
S4 DRG. The single axon branches within the detrusor muscle, giving rise to numerous 
“branching-type” axons in the smooth muscle layers. The fine nerve endings indicated by arrow 
b is shown on expanded magnification in panel B. The urothelium was sharp dissected away 
from the detrusor muscle to confirm the axon and nerve ending ramified within the detrusor 
muscle itself.  
 
 
